Rational phytotherapy as an alternative treatment for acute respiratory tract infections

被引:1
作者
Zwolinska, Danuta [1 ]
机构
[1] Uniwersytet Med Wroclawiu, Katedra & Klin Nefrol Pediat, Wroclaw, Poland
来源
PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE | 2022年 / 18卷 / 02期
关键词
phytotherapy; respiratory tract infections; Pelargonium sidoides; elderberry; COVID-19; PELARGONIUM-SIDOIDES; EPS; 7630; VIRAL-INFECTIONS; DOUBLE-BLIND; EXTRACT; EFFICACY; CHILDREN; TOLERABILITY; MEDICINE; SAFETY;
D O I
10.15557/PiMR.2022.0020
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Acute respiratory tract infections in children are the most common reason for primary care appointments. Although the vast majority of cases are viral, antibiotic therapy, which involves more risks than benefits in these patients, is still overused, contributing to antibiotic resistance and adverse effects. Almost all recommendations indicate avoiding such approach and use symptomatic treatment supplemented with plant-based formulations instead. There is abundance of different medicinal plants that contain compounds with proven antiviral, antioxidant and immunomodulatory properties, which effectively support the combat against respiratory infections, especially if combined in one product (synergism). Contemporary rational phytotherapy assumes a scientific approach to plant-derived formulations, and it should be emphasised that the registration of herbal medicines is subject to the same restrictions as in the case of synthetic drugs. The paper discusses the composition and activity of compounds contained in medicinal plants and their role in the treatment of respiratory tract infections, with main focus on Pelargonium sidoides and elderberry, the properties of which have so far been the most thoroughly investigated and described. Their efficacy and safety in different forms of respiratory tract infections were discussed, showing that the use of products based on these plants significantly reduces disease duration and severity of clinical symptoms, as well as the need to use other agents, including antibiotics. The reasons for the use of Pelargonium sidoides preparations in the prevention and treatment of COVID-19 were also presented.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 45 条
[1]  
[Anonymous], 1992, International Classification of Diseases, 10th Revision (ICD- 10)
[2]  
Bachert Claus, 2020, Clinical Phytoscience, V6, DOI [10.1186/s40816-020-00231-7, 10.1186/s40816-020-00231-7]
[3]  
Bereznoy VV, 2003, ALTERN THER HEALTH M, V9, P68
[4]  
Bladt S, 2007, PHYTOMEDICINE, V14, P2, DOI 10.1016/j.phymed.2006.11.030
[5]   A historical, scientific and commercial perspective on the medicinal use of Pelargonium sidoides (Geraniaceae) [J].
Brendler, T. ;
van Wyk, B. -E. .
JOURNAL OF ETHNOPHARMACOLOGY, 2008, 119 (03) :420-433
[6]   Pelargonium sidoides extract EPs 7630: a review of its clinical efficacy and safety for treating acute respiratory tract infections in children [J].
Careddu, Domenico ;
Pettenazzo, Andrea .
INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2018, 11 :91-98
[7]   Coronaviruses and Nature's Pharmacy for the Relief of Coronavirus Disease 2019 [J].
Chinsembu, Kazhila C. .
REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY, 2020, 30 (05) :603-621
[8]   Overprescribing and Inappropriate Antibiotic Selection for Children With Pharyngitis in the United States, 1997-2010 [J].
Dooling, Kathleen L. ;
Shapiro, Daniel J. ;
Van Beneden, Chris ;
Hersh, Adam L. ;
Hicks, Lauri A. .
JAMA PEDIATRICS, 2014, 168 (11) :1073-1074
[9]  
Fokkens WJ, 2012, RHINOLOGY, V50, P1
[10]   Potential of herbal products in prevention and treatment of COVID-19. Literature review [J].
Gajewski, Aleksander ;
Kosmider, Anna ;
Nowacka, Aleksandra ;
Puk, Oskar ;
Wicinski, Michal .
BIOMEDICINE & PHARMACOTHERAPY, 2021, 143